Abstract
The Ca2+ channel antagonists are a heterogeneous group of agents that define a common target yet exhibit remarkable selectivity and subtlety of action. The L-type channel with which these drugs interact dominates functionally the cardiovascular system, and this underscores the uses of these drugs in cardiovascular disorders. That these drugs exhibit cardiac: vascular selectivity and regional vascular selectivity is defined by a number of factors including pharmacokinetic, channel type and subtype, state-dependent interactions, pathology and the Ca2+ mobilization process affected.
| Original language | English |
|---|---|
| Pages (from-to) | 529-546 |
| Number of pages | 18 |
| Journal | Principles of Medical Biology |
| Volume | 8 |
| Issue number | C |
| DOIs | |
| State | Published - 1997 |
Fingerprint
Dive into the research topics of 'Chapter 27 The tissue specificity of calcium antagonists'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver